Bio‐Ceramics With Clinical Applications 2014
DOI: 10.1002/9781118406748.ch12
|View full text |Cite
|
Sign up to set email alerts
|

Ceramics for Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
3
1
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 268 publications
0
2
0
2
Order By: Relevance
“…The use of AI-driven applications, such as predictive maintenance, has promise in reducing downtime and improving overall equipment effectiveness via the anticipation of equipment faults prior to their actual occurrence. The use of this proactive strategy not only serves to reduce interruptions in production, but also enhances the efficiency of resource allocation and decreases maintenance expenses (Manzano and Whitford, 2023). In addition, the use of artificial intelligence (AI) in conjunction with robotic automation and smart manufacturing systems allows for the efficient integration of data across the entire value chain.…”
Section: Ai In Pharmaceutical Manufacturingmentioning
confidence: 99%
“…The use of AI-driven applications, such as predictive maintenance, has promise in reducing downtime and improving overall equipment effectiveness via the anticipation of equipment faults prior to their actual occurrence. The use of this proactive strategy not only serves to reduce interruptions in production, but also enhances the efficiency of resource allocation and decreases maintenance expenses (Manzano and Whitford, 2023). In addition, the use of artificial intelligence (AI) in conjunction with robotic automation and smart manufacturing systems allows for the efficient integration of data across the entire value chain.…”
Section: Ai In Pharmaceutical Manufacturingmentioning
confidence: 99%
“…Considering that in the case of bone cancer, the chemotherapeutic drugs should be administered and to reach the desired amounts of drug in the targeted tissue how much chemotherapeutic drug is in need. Without a doubt, systemic administration has devastating effects on other organs in the case of bone cancer [38]. On the other hand, localized controlled release can provide desired drug concentration in the targeted tissue and also it is able to enhance drug bioavailability [39,40].…”
Section: Localized Drug Deliverymentioning
confidence: 99%
“…Aktywnym miejscem odpowiedzialnym za adsorpcję poprzez tworzenie wiązań wodorowych są powierzchniowe, strukturalne grupy hydroksylowe. Substancje lecznicze mogą ulegać adsorpcji zarówno na nanocząstkach hydroksyapatytu, granulkach oraz porowatych kształtkach [26,30]. Oczywiście, adsorpcja zależeć będzie od wielu czynników, między innymi od struktury związku adsorbowanego, powierzchni właściwej hydroksyapatytu, porowatości, pH, obecności innych jonów/substancji adsorbowanych.…”
Section: Wprowadzanie Substancji Leczniczejunclassified
“…Systemy uwalniania substancji leczniczych mogą być utworzone nie tylko z nieorganicznego hydroksyapatytu, ale także z kompozytów z polimerami [30]. W takich przypadkach można często wykorzystać obecność różnych grup funkcyjnych polimerów do utworzenia wiązań chemicznych z wprowadzaną substancją leczniczą.…”
Section: Wprowadzanie Substancji Leczniczejunclassified